Position in ABUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,197,987
+$775,560 QoQ
Shares Held
4,207,914
-2.5% QoQ
Ownership
2.13%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#8
of 175 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABUS Over Time
Shares Held
Position Value (USD)
Derivatives in ABUS
reported options exposure · as of Dec 31, 2023CallValue
$187,500
CallShares
75,000
PutValue
$187,500
PutShares
75,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,706,205,847 across 455 Biotechnology names. ABUS ranks #17 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in ABUS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,197,987 | 4,207,914 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $19,422,427 | 4,316,095 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,715,649 | 356,684 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,290,857 | 284,330 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $1,256,263 | 406,558 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $789,315 | 226,165 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $975,287 | 298,253 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $1,047,311 | 272,029 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $148,425 | 48,034 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $230,099 | 89,186 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $539,857 | 215,943 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $187,500 | 75,000 | Put | Sole | 2026-03-24 | |
| 2023-12-31 | $187,500 | 75,000 | Call | Sole | 2026-03-24 | |
| 2023-09-30 | $267,644 | 131,845 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $110,157 | 47,895 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $174,400 | 57,558 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $71,074 | 30,504 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $8,745 | 4,579 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $14,688 | 5,420 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $997,691 | 334,796 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,055,955 | 271,454 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,726,105 | 635,456 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $30,035 | 9,913 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $342,553 | 102,869 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,388 | 391 | Shares | Sole | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||